A recent study found that over four years, participants taking Wevovy as indicated experienced an average weight loss of 10.2% body weight and a reduction in waist circumference of 7.7cm
Read Article What Supplements Does Andrew Huberman Recommend
A: Brand tirzepatide has robust trial data, precise dosing, FDA oversight, insurance coverage, and manufacturer support
This advanced synthetic peptide mimics endogenous GLP-1 hormone action while providing enhanced stability and extended half-life through DPP-4 enzyme resistance
That's because Mounjaro is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, which may make it more effective at controlling blood sugar levels and supporting weight loss
Sahin M, Gursoy A, Erdogan MF